Bibliographic references on Probiotics for Kids

(1) Szajewska H, Kołodziej M. Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment Pharmacol Ther. 2015;42(10):1149-1157. doi:10.1111/apt.13404,

(2 )Sidor, Andrzej & Gramza Michalowska, Anna. (2014). Advanced research on the antioxidant and health benefit of elderberry (Sambucus nigra) in food – a review. Journal of Functional Foods. 18. 10.1016/j.jff.2014.07.012.

(3) Kołodziej M, Szajewska H. Lactobacillus reuteri DSM 17938 in the prevention of antibiotic-associated diarrhoea in children: protocol of a randomised controlled trial. BMJ Open. 2017;7(1): e013928. DOI: 10.1136/bmjopen-2016-013928

(4) Francavilla, R., Lionetti, E., Castellaneta, S., Ciruzzi, F., Indrio, F., Masciale, A., Fontana, C., La Rosa, M.M., Cavallo, L. and Francavilla, A., 2012. Randomised clinical trial: Lactobacillus reuteri DSM 17938 vs. placebo in children with acute diarrhoea – a double-blind study. Alimentary Pharmacology and Therapeutics 36: 363-369.

(5) Dinleyici EC, Dalgic N, Guven S, et al. Lactobacillus reuteri DSM 17938 shortens acute infectious diarrhea in a pediatric outpatient setting. J Pediatr (Rio J). 2015;91:392-396.

(6) Urbanska M, Szajewska H. The efficacy of Lactobacillus reuteri DSM 17938 in infants and children: a review of the current evidence. Eur J Pediatr. 2014;173:1327-1337.

(7) Savino F. et al., (2015), ‘Preventive effects of oral probiotic on infantile colic: a prospective, randomised, blinded, controlled trial using Lactobacillus reuteri DSM 17938’. Benef. Microbes, 6(3):245-251, ePub 8 Dec. 2014.

(8) Weizman Z, Abu-Abed J, Binsztok M. Lactobacillus reuteri DSM 17938 for the Management of Functional Abdominal Pain in Childhood: A Randomized, Double-Blind, Placebo-Controlled Trial. J Pediatr. 2016;174:160-164.e1. doi:10.1016/j.jpeds.2016.04.003

(9) Kalman, D.S., Schwartz, H.I., Alvarez, P. et al. A prospective, randomized, double-blind, placebo-controlled parallel-group dual site trial to evaluate the effects of a Bacillus coagulans-based product on functional intestinal gas symptoms. BMC Gastroenterol 9, 85 (2009). https://doi.org/10.1186/1471-230X-9-85

(10) Rogha M, Esfahani MZ, Zargarzadeh AH. The efficacy of a synbiotic containing Bacillus Coagulans in treatment of irritable bowel syndrome: a randomized placebo-controlled trial. Gastroenterol Hepatol Bed Bench. 2014;7(3):156-163.

(11) Anaya-Loyola MA, Enciso-Moreno JA, Lopez-Ramos JE, Garcia-Marin G, Orozco Alvarez MY, Vega-Garcai AM, Mosqueda J, Garcia-Gutierrez DG, Keller D, Perez-Ramirez IF. Bacillus coagulans GBI-30, 6086 decreases upper respiratory and gastrointestinal tract symptoms in healthy Mexican scholar-aged children by modulating immune-related proteins. (2019) 

(12) Majeed M, Nagabhushanam K, Natarajan S, et al. Bacillus coagulans MTCC 5856 supplementation in the management of diarrhea predominant Irritable Bowel Syndrome: a double blind randomized placebo controlled clinical study. Nutr J. 2016;15:21. Published 2016 Feb 27. doi:10.1186/s12937-016-0140-6

(13) Madempudi, R.S., Ahire, J.J., Neelamraju, J. et al. Randomized clinical trial: the effect of probiotic Bacillus coagulans Unique IS2 vs. placebo on the symptoms management of irritable bowel syndrome in adults. Sci Rep 9, 12210 (2019). https://doi.org/10.1038/s41598-019-48554-x

(14) Labellarte, G. and Maher, M. (2019) Tolerance and Effect of a Probiotic Supplement Delivered in Capsule Form. Food and Nutrition Sciences, 10, 626-634. doi: 10.4236/fns.2019.106046.

(15) Lorenzo-Zúñiga V, Llop E, Suárez C, Alvarez B, Abreu L, Espadaler J, et al. I.31, a new combination of probiotics, improves irritable bowel syndrome-related quality of life. World J Gastroenterol. 2014 Jul 14;20(26):8709–16.

(16). McKay DL, Blumberg JB. A review of the bioactivity and potential health benefits of peppermint tea (Mentha piperita L.). Phytother Res. 2006 Aug;20(8):619-33. doi: 10.1002/ptr.1936. PMID: 16767798.

(17) Dolin BJ. Effects of a proprietary Bacillus coagulans preparation on symptoms of diarrhea-predominant irritable bowel syndrome. Methods Find Exp Clin Pharmacol. 2009;31(10):655-659. doi:10.1358/mf.2009.31.10.1441078

(18) Szymański H, Armańska M, Kowalska-Duplaga K, Szajewska H. Bifidobacterium longum PL03, Lactobacillus rhamnosus KL53A, and Lactobacillus plantarum PL02 in the prevention of antibiotic-associated diarrhea in children: a randomized controlled pilot trial. Digestion. 2008;78(1):13-17. doi:10.1159/000151300

(19) Jirapinyo P, Densupsoontorn N, Thamonsiri N, et al. Prevention of antibiotic-associated diarrhea in infants by probiotics. J Med Assoc Thai 2002;85(Suppl 2):S739-42.

(20)Sur D, Manna B, Niyogi SK, et al. Role of probiotic in preventing acute diarrhoea in children: a community-based, randomized, double-blind placebo-controlled field trial in an urban slum. Epidemiol Infect. 2011;139(6):919-926. doi:10.1017/S0950268810001780

(21)Janvier A, Malo J, Barrington KJ. Cohort study of probiotics in a North American neonatal intensive care unit [published correction appears in J Pediatr. 2014 Jun;164(6):1503]. J Pediatr. 2014;164(5):980-985. doi:10.1016/j.jpeds.2013.11.025

(22)Latvala, S., et al. “Health Benefits of a Combination Probiotics; FlorMidabil[TM].” International Journal of Probiotics & Prebiotics, vol. 14, 2019, p. 9+. Gale Academic OneFile

(23)Paineau, Damien & Carcano, Didier & Leyer, Gregory & Darquy, Sylviane & Alyanakian, Marie-Alexandra & Simoneau, Guy & Bergmann, Jean-François & Brassart, Dominique & Bornet, Francis R. J. & Ouwehand, Arthur. (2008). Effects of seven potential probiotic strains on specific immune responses in healthy adults: A double-blind, randomized, controlled trial. FEMS immunology and medical microbiology. 53. 107-13. 10.1111/j.1574-695X.2008.00413.x.

(24)García Trallero O, Herrera Serrano L, Bibián Inglés M, Roche Vallés D, Rodríguez AM. Effect of the administration of a probiotic with a combination of Lactobacillus and Bifidobacterium strains on antibiotic-associated diarrhea. Rev Esp Quimioter. 2019;32(3):268-272.

(25)Zupancic K, Kriksic V, Kovacevic I, Kovacevic D. Influence of Oral Probiotic Streptococcus salivarius K12 on Ear and Oral Cavity Health in Humans: Systematic Review. Probiotics Antimicrob Proteins. 2017;9(2):102-110. doi:10.1007/s12602-017-9261-2

(26) Di Pierro F, Zanvit A, Nobili P, Risso P, Fornaini C. Cariogram outcome after 90 days of oral treatment with Streptococcus salivarius M18 in children at high risk for dental caries: results of a randomized, controlled study. Clin Cosmet Investig Dent. 2015;7:107-113. Published 2015 Oct 3. doi:10.2147/CCIDE.S93066

(27)Cui, X and Wure, G. 2003. The treatment of 62 cases of rotavirus gastroenteritis by Biostime probiotics. Chin J Gen Med 5:53-54.

(28)Jiang X. 2008. Clinical evaluation of Biostime in the treatment of children with persistent diarrhea. The 6th Chin National Conf on Pediatr Microecol 142-145.

(29)Chen L, Ouyang L-J, Liao W-J, Zhang W-H. 2007. Mucous membrane immunity enhanced by taking Biostime probiotics. Chin J Ecol 19:137-141.

(30)Cazzola M, Pham-Thi N, Kerihuel JC, Durand H, Bohbot S. 2010b. Efficacy of a synbiotic supplementation in the prevention of common winter diseases in children: a randomized, double-blind, placebo-controlled pilot study. Ther Adv. Respir Dis 4:271-278.

(31)Jennifer C Dennis-Wall, Tyler Culpepper, Carmelo Nieves, Jr., Cassie C Rowe, Alyssa M Burns, Carley T Rusch, Ashton Federico, Maria Ukhanova, Sheldon Waugh, Volker Mai, Mary C Christman, Bobbi Langkamp-Henken, Probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial, The American Journal of Clinical Nutrition, Volume 105, Issue 3, March 2017, Pages 758–767,

(32)Kawahara T, Makizaki Y, Oikawa Y, et al. Oral administration of Bifidobacterium bifidum G9-1 alleviates rotavirus gastroenteritis through regulation of intestinal homeostasis by inducing mucosal protective factors. PLoS One. 2017;12(3):e0173979. Published 2017 Mar 27. doi:10.1371/journal.pone.0173979

(33)M. Margreiter, K. Ludl, W. Phleps and S.T. Kaehler.Therapeutic value of a Lactobacillus gasseri and Bifidobacterium longum fixed bacterium combination in acute diarrhea: a randomized, double-blind, controlled clinical trial. 2006; 44: 207-215. doi: 10.5414/CPP44207.

(34)Acidophilus Milk Products: A Review of Potential Benefits to Consumers Gilliland S.E.(1989) Journal of Dairy Science, 72 (10) , pp. 2483-2494.

(35) Lee Y. and Salminen S., (2009), Handbook of Probiotic and Prebiotics. 2nd edition, Hoboken: John Wiley & Sons.
Lindfors K., (2008), ‘Live probiotic Bifidobacterium lactis bacteria inhibit the toxic effects induced by wheat gliadin in epithelial cell culture’. Clin. Exp. Immunol., 152 (3):552-558.

(36) Jirapinyo P, Densupsoontorn N, Thamonsiri N, et al. Prevention of antibiotic-associated diarrhea in infants by probiotics. J Med Assoc Thai 2002;85(Suppl 2):S739-42.

(37) Lönnermark E, Friman V, Lappas G, Sandberg T, Berggren A, Adlerberth I. Intake of Lactobacillus plantarum reduces certain gastrointestinal symptoms during treatment with antibiotics. J Clin Gastroenterol. 2010;44(2):106-112. doi:10.1097/MCG.0b013e3181b2683f

(38) Engelbrektson, Anna & Korzenik, Joshua & Pittler, Arlyn & Sanders, Mary & Klaenhammer, Todd & Leyer, Gregory & Kitts, Christopher. (2009). Probiotics to minimize the disruption of faecal microbiota in healthy subjects undergoing antibiotic therapy. Journal of medical microbiology. 58. 663-70. 10.1099/jmm.0.47615-0.